Skip to main content
UniHealth

Doctor search

Victoria E. Wang, MD

Hematology/Oncology · San Francisco

NPI 1629264098

Medicare standing
Clear
Enrolled, allowed to bill and order, not excluded
Plans that list them
14
3 carriers
Offices
10

Offices

10 locations · UCSF Medical Group Business Services · Regents of the University of California · Sutter Bay Medical Foundation · University of California San Francisco

Looking this up.

Hospitals listed: UCSF Medical Center. That is not proof they admit you there this week.

Plans that list them

14 plans · 3 carriers

A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Wang’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.

14 of 14 plans

Plans whose provider directory lists this clinician
Alignment Health BreathEasy (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Clarity (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Harmony (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes CalPlus (HMO C-SNP)Alignment Health PlanListedOct 3, 2026
Alignment Health Heart & Diabetes Care (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Heart & Diabetes Choice (HMO C-SNP)Alignment Health PlanListedSep 28, 2026
Alignment Health Honor+ Plan (HMO)Alignment Health PlanListedOct 3, 2026
Alignment Health My Choice CalCare (HMO)Alignment Health PlanListedOct 3, 2026
Central Health Classic Care Plan III (HMO)Central Health Medicare PlanListedAug 15, 2026
Central Health Dual Access Plan (HMO D-SNP)Central Health Medicare PlanListedAug 15, 2026
Central Health Embrace Choice Plan (HMO C-SNP)Central Health Medicare PlanListedAug 15, 2026
Central Health Valor Care Plan (HMO)Central Health Medicare PlanListedAug 15, 2026
DualConnect (HMO D-SNP)Santa Clara Family Health PlanListedSep 1, 2026

California Medical Board record

Licence A116118 · Current

Licensed to practise in California · since 2011 · expires 2028-07-31 · Harvard Medical School.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Hospitals they work in

1 hospital

These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.

  • UCSF Medical CenterSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Other · Has an emergency department · Birthing-friendlyPart of University of California Health, which runs 12 hospitalsHome of UCSF Helen Diller Family Comprehensive Cancer Center, a National Cancer Institute designated comprehensive cancer centrePatients rate it 4 of 5 · 81% would definitely recommend it
    Overall rating: 4 of 5 starsWorse than the national rate — Perioperative pulmonary embolism or deep vein thrombosis rate: 4.9 (3.79 to 6.02) · 7,590 cases, Jul 2022 – Jun 2024Worse than the national rate — Rate of inpatient admissions for patients receiving outpatient chemotherapy: 12.8 (11.3 to 14.4) · 2,019 cases, Jan 2024 – Dec 2024Better than the national rate — Death rate among surgical inpatients with serious treatable complications: 139.4 (110.22 to 168.58) · 452 cases, Jul 2022 – Jun 2024Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.622, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.626, Oct 2024 – Sep 2025Better than the national rate — MRSA Bacteremia: 0.491, Oct 2024 – Sep 2025Better than the national rate — Ratio of unplanned hospital visits after hospital outpatient surgery: 0.8 (0.7 to 1) · 2,336 cases, Jan 2024 – Dec 2024
See every measure and the patient survey for UCSF Medical Center

Behind the star rating — Deaths: 5 better, 3 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 3 better, 5 the same, 3 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.

Every scored measure at UCSF Medical Center
Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths4.9 (3.79 to 6.02) · 7,590 casesWorseJul 2022 – Jun 2024
Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits12.8 (11.3 to 14.4) · 2,019 casesWorseJan 2024 – Dec 2024
Death rate among surgical inpatients with serious treatable complicationsComplications and deaths139.4 (110.22 to 168.58) · 452 casesBetterJul 2022 – Jun 2024
Central Line Associated Bloodstream Infection (ICU + select Wards)Infections0.622BetterOct 2024 – Sep 2025
Clostridium Difficile (C.Diff)Infections0.626BetterOct 2024 – Sep 2025
MRSA BacteremiaInfections0.491BetterOct 2024 – Sep 2025
Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits0.8 (0.7 to 1) · 2,336 casesBetterJan 2024 – Dec 2024
Abdominopelvic accidental puncture or laceration rateComplications and deaths1.24 (0.58 to 1.9) · 4,689 casesNo differentJul 2022 – Jun 2024
CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths1.05 (0.89 to 1.2)No differentJul 2022 – Jun 2024
Death rate for CABG surgery patientsComplications and deaths1.9 · 89 casesNoneJul 2022 – Jun 2025
Death rate for COPD patientsComplications and deaths7.5 · 85 casesNoneJul 2022 – Jun 2025
Death rate for heart attack patientsComplications and deaths10.1 · 132 casesNoneJul 2022 – Jun 2025
Death rate for heart failure patientsComplications and deaths6.6 · 454 casesNoneJul 2022 – Jun 2025
Death rate for pneumonia patientsComplications and deaths10.3 · 618 casesNoneJul 2022 – Jun 2025
Death rate for stroke patientsComplications and deaths9.6 · 380 casesNoneJul 2023 – Jun 2025
Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths2.7 · 5,000 casesNoneJul 2024 – Jun 2025
Iatrogenic pneumothorax rateComplications and deaths0.22 (0.06 to 0.38) · 15,965 casesNo differentJul 2022 – Jun 2024
In-hospital fall-associated fracture rateComplications and deaths0.2 (0.05 to 0.35) · 17,859 casesNo differentJul 2022 – Jun 2024
Postoperative acute kidney injury requiring dialysis rateComplications and deaths0.85 (0 to 1.83) · 4,184 casesNo differentJul 2022 – Jun 2024
Postoperative hemorrhage or hematoma rateComplications and deaths2 (1.1 to 2.9) · 6,516 casesNo differentJul 2022 – Jun 2024
Postoperative respiratory failure rateComplications and deaths7.35 (4.49 to 10.21) · 3,989 casesNo differentJul 2022 – Jun 2024
Postoperative sepsis rateComplications and deaths5 (3.22 to 6.77) · 4,087 casesNo differentJul 2022 – Jun 2024
Postoperative wound dehiscence rateComplications and deaths1.95 (0.74 to 3.15) · 2,034 casesNo differentJul 2022 – Jun 2024
Pressure ulcer rateComplications and deaths0.95 (0.63 to 1.28) · 15,431 casesNo differentJul 2022 – Jun 2024
Rate of complications for hip/knee replacement patientsComplications and deaths4 · 399 casesNoneApr 2023 – Mar 2025
Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections0.899No differentOct 2024 – Sep 2025
SSI - Abdominal HysterectomyInfections0.689No differentOct 2024 – Sep 2025
SSI - Colon SurgeryInfections1.224No differentOct 2024 – Sep 2025
Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits16 · 156 casesNoneJul 2023 – Jun 2025
Heart failure (HF) 30-Day Readmission RateUnplanned return visits20 · 564 casesNoneJul 2023 – Jun 2025
Hospital return days for heart attack patientsUnplanned return visits60.3 · 160 casesNoneJul 2022 – Jun 2025
Hospital return days for heart failure patientsUnplanned return visits-9.7 · 550 casesNoneJul 2022 – Jun 2025
Hospital return days for pneumonia patientsUnplanned return visits44.1 · 660 casesNoneJul 2022 – Jun 2025
Pneumonia (PN) 30-Day Readmission RateUnplanned return visits16.8 · 667 casesNoneJul 2023 – Jun 2025
Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits5.7 (4.8 to 6.7) · 2,019 casesNo differentJan 2024 – Dec 2024
Rate of readmission after hip/knee replacementUnplanned return visits6 · 421 casesNoneJul 2023 – Jun 2025
Rate of readmission for CABGUnplanned return visits10.5 · 53 casesNoneJul 2023 – Jun 2025
Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits20 · 107 casesNoneJul 2023 – Jun 2025
Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits13.9 (11.3 to 17.1) · 3,247 casesNo differentJan 2022 – Dec 2024

What patients said (3,181 patients answered, 25% of those asked)

Patient survey stars by topic at UCSF Medical Center
Cleanliness4
Nurse communication4
Doctor communication4
Communication about medicines3
Discharge information4
Overall hospital rating4
Quietness2
Recommend hospital5
Share of patients giving the best answer at UCSF Medical Center
Room was "always" clean71%
Nurses "always" communicated well80%
Doctors "always" communicated well80%
Staff "always" explained61%
Yes, staff "did" give patients this information88%
Yes, staff "did" give patients information about help after discharge87%
Doctors "always" explained things so they could understand74%
Doctors "always" listened carefully78%
Doctors "always" treated them with courtesy and respect86%
Patients who gave a rating of "9" or "10" (high)76%
Staff "always" explained new medications75%
Nurses "always" explained things so they could understand77%
Nurses "always" listened carefully78%
Nurses "always" treated them with courtesy and respect86%
"Always" quiet at night50%
"YES", patients would definitely recommend the hospital81%
Staff "always" explained possible side effects46%
Yes, staff "did" give patients information about possible symptoms90%

Original Medicare doctor bills

$30,414

Medicare paid this office $30,414 for 145 people. Most of that is long return visits and Botox.

This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.

Largest Original Medicare bills
Long return visit (40+ min)32$13,676$128
Return visit (30+ min)93$10,015$108
Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's32$1,553$15

Who their Medicare patients are

145 Original Medicare patients in 2024. Average age 74 · Under 65 8% · 85 and older 12% · Women 59% · Also on Medicaid 16% · Health risk score 1.33. At or below the middle of the specialty; the typical hematology-oncology clinician is at 2.04.

Conditions among them: High blood pressure 59% · Coronary heart disease 24% · Diabetes 23% · Cancer 23% · Chronic kidney disease 19% · Atrial fibrillation 17% · Heart failure 12% · Depression 11% · COPD 8% · Stroke 8%.

The office billed $153,854, Medicare allowed $40,316 and paid $30,414; for 726 services of 31 kinds; $127 of it was for drugs given in the office and $30,287 for care.

Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.

Year by year

Original Medicare by year
2024145726741.33$153,854$30,414
2023113240751.39$121,422$23,587
2022169675761.26$143,893$31,358
2021207652751.20$136,588$31,999
202094181751.29$66,848$14,243
2019113607781.03$72,008$21,457
2018119246761.26$77,530$15,717
201770204771.47$89,012$14,149
201648145741.63$72,576$10,955
201568397741.22$67,029$11,540
201452452721.11$34,879$6,578
201352107761.10$11,843$3,501

Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.

See the services billed each year

2023: 2 services

Original Medicare services billed in 2023
Long return visit (40+ min)30$12,046$122
Return visit (30+ min)62$7,140$115

2022: 5 services

Original Medicare services billed in 2022
Return visit (30+ min)96$11,098$112
Long return visit (40+ min)31$9,057$118
Long return visit (40+ min)22$5,519$162
Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen16$810$51
Automated urinalysis test19$42$2

2021: 7 services

Original Medicare services billed in 2021
Return visit (30+ min)125$14,155$113
Long return visit (40+ min)28$8,475$128
New patient visit (60+ min)13$2,162$166
Long return visit (40+ min)15$2,017$134
Amplifed dna or rna probe detection of severe acute respiratory syndrome coronavirus 2 (covid-19) antigen26$1,334$51
Short return visit (20+ min)11$937$85
Automated urinalysis test11$25$2

2020: 2 services

Original Medicare services billed in 2020
Return visit (30+ min)47$3,952$84
Return visit (30+ min)18$1,927$69

2019: 3 services

Original Medicare services billed in 2019
Return visit (30+ min)78$6,752$83
Short return visit (20+ min)22$1,539$70
Automated urinalysis test12$29$2

2018: 4 services

Original Medicare services billed in 2018
Return visit (30+ min)60$5,628$94
Long return visit (40+ min)12$4,976$90
Short return visit (20+ min)31$1,847$58
Long return visit (40+ min)12$1,539$128

2017: 3 services

Original Medicare services billed in 2017
Long return visit (40+ min)19$8,195$95
Return visit (30+ min)22$2,056$93
Short return visit (20+ min)23$1,362$59

2016: 3 services

Original Medicare services billed in 2016
Long return visit (40+ min)14$5,051$95
New patient visit (60+ min)11$1,625$148
Short return visit (20+ min)12$673$56

2015: 4 services

Original Medicare services billed in 2015
Return visit (30+ min)11$2,165$68
Short return visit (20+ min)28$1,664$57
New patient visit (60+ min)11$1,545$140
Return visit (30+ min)15$1,465$98

2014: 2 services

Original Medicare services billed in 2014
New patient visit (60+ min)13$1,954$150
Short return visit (20+ min)14$1,022$68

2013: 2 services

Original Medicare services billed in 2013
Short return visit (20+ min)22$1,248$57
Short return visit14$586$42

Medicaid work

$961 in 2021

Medicaid paid $961 for 36 billed services this clinician did in 2021, up to 20 people in a month for one service.

Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.

Largest Medicaid services in 2021
Return visit (30+ min)36$961
Medicaid work by year
202136120$961

Drugs they prescribed that Part D paid

$512,408

Pharmacies billed $512,408 in 2024.

This is pharmacy cost, not the office bill, and not what patients paid.

108 generic and fewer than 11 brand-name prescriptions · $512,408 in drug cost · 34 antibiotic prescriptions to 26 people.

Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.

Largest Part D drug costs
Tagrisso13$223,920$17,225
Ondansetron12$45$4

Year by year

Part D prescribing by year
202415367NoneNone$512,408
202311744NoneNone$318,899
202212369NoneNone$331,694
202111876None17%$16,226
20208449None25%$134,199
20198859None26%$206,504
201811747None35%$511,097
201713336None44%$365,938
201613425None47%$378,142
2015178367% (12)35%$281,415
2014672618% (12)21%$65,044
20133725NoneNone$721

Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.

See the drugs prescribed each year

2023: 1 drug

Part D drugs prescribed in 2023
Ondansetron11$148$13

2019: 2 drugs

Part D drugs prescribed in 2019
Tagrisso13$201,584$15,506
Azithromycin12$67$6

2018: 1 drug

Part D drugs prescribed in 2018
Tagrisso25$383,519$15,341

2017: 3 drugs

Part D drugs prescribed in 2017
Tagrisso13$190,863$14,682
Tarceva21$165,835$7,897
Clindamycin Phosphate11$499$45

2016: 2 drugs

Part D drugs prescribed in 2016
Tarceva48$346,940$7,228
Clindamycin Phosphate21$1,549$74

2015: 4 drugs

Part D drugs prescribed in 2015
Tarceva38$254,895$6,708
Clindamycin Phosphate23$2,053$89
Ondansetron18$262$15
Prochlorperazine Maleate11$85$8

Money from drug and device companies

$890 in 2025

Industry payments by year
202522$890$890
202422$918$918
202111$373$373
201911None$11

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
Daiichi SankyoVanflyta$650
1 payment
  • Consulting for Vanflyta · 2025-09-22 · $650
Dr.Reddy's LaboratoriesNone$240
1 payment
  • Consulting · 2025-09-22 · $240
See all 2 published payments
Every published payment
Daiichi SankyoConsulting · 2025-09-22Vanflyta$650
Dr.Reddy's LaboratoriesConsulting · 2025-09-22None$240
See earlier years (2024, 2021, 2019)

2024: $918

Payments by company in 2024
AstraZeneca Pharmaceuticals LPTruqap$525
1 payment
  • Consulting for Truqap · 2024-12-12 · $525
TerSera TherapeuticsNone$393
1 payment
  • Consulting · 2024-07-16 · $393

2021: $373

Payments by company in 2021
Becton Dickinson andNone$373
1 payment
  • Consulting · 2021-03-05 · $373

2019: $11

Payments by company in 2019
PfizerLorbrena$11
1 payment
  • Education for Lorbrena · 2019-10-31 · $11

Professional record

NPI
1629264098
Licence
CA A116118California A116118: Current · expires 2028-07-31
Trained
Harvard Medical School, 2006
Group
UCSF Medical Group Business Services · Regents of the University of California · Sutter Bay Medical Foundation · University of California San Francisco
Video visits
Lists video visits
Gender
Female
More record details
Sole proprietor
No
Taxonomy
Federal specialty code 207RH0003X (207RH0003X)
Mailing address
505 Parnassus Ave, M1286, San Francisco, CA, 94143
NPI first listed
2007-09-19
NPI last updated
2012-10-23

This is when the NPI record was last certified, not a medical board exam.